Publication | Open Access

Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial

Non-small-cell Lung CancerMedicinePathologyCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung Cancer